World Health Organization

This report is from a consultation of experts held jointly by the World Health Organization (WHO) and Rockefeller Foundation. The report makes recommendations to the Stop TB Partnership (the Partnership) for confronting the health care workforce crisis in tuberculosis (TB) control. This is identified through three key areas for action: (1) building the evidence base for planning and advocacy, (2) positioning and advocacy, and (3) capacity building.

This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited. The report demonstrates that lessons from a Latin American perspective on community-based TB care can help to understand and identify the role that the community plays in TB control in the region.

This report describes community-based tuberculosis care in Latin America, and field visits to selected community-based TB care projects to understand the origin, performance, acceptability, effectiveness, and sustainability of some existing DOTS projects. Three sites in Colombia and two in Bolivia, where the DOTS strategy is already implemented, were visited. The report demonstrates that lessons from a Latin American perspective on community-based TB care can help to understand and identify the role that the community plays in TB control in the region.

This report describes the progress of the Stop TB Partnership. It reports that TB control is succeeding around the world. The challenges include increasing and sustaining new funding levels; strengthening the public health system, including the availability, capacity, and motivation of human resources; empowering households and communities; engaging providers in the private and other sectors; and creating and adopting new technology, such as diagnostics, drugs, and vaccines.

This book provides a basis for the diagnosis and management of tuberculosis. It is presented in a question-and-answer format, with subject matter grouped under the three headings: Case Detection, Treatment, and Monitoring.

Aimed at provincial or district level staff responsible for training health facility staff who detect and treat cases of tuberculosis (TB), this guide explains options for using the course "Management of Tuberculosis: Training for Health Facility Staff." This guide is for the staff who will implement training at the provincial or district level, according to directives from the national level.

This compendium report provides a detailed review of monitoring and evaluation (M&E) for national TB programs and indicators for measuring DOTS implementation and expansion. The review includes information on M&E for TB control programs, sources of data, and effective use of M&E data for program improvement and advocacy.

In this online 60-second Public Service Announcement, Winston Zulu, a TB/HIV advocate from Zambia, says that TB is the biggest killer of People Living with HIV (PLWH). He advocates that he is still alive because he got access to TB treatment on time. A 10-minutes flash movie accompanies this PSA.

In this flash film, Winstone Zulu, a TB/HIV advocate from Zambia, says that TB is the leading killer of AIDS patients living in Africa. From his own experience of living with both AIDS and TB, and having been cured of TB himself, he states that there is a desperate need for TB patients to be treated with TB drugs, as TB can be cured. He emphasizes that fighting AIDS in Africa means fighting TB. A 60-second PSA accompanies this flash film.

This book was developed to assist in the management of TB and HIV/AIDS programs that are implementing or planning to implement collaborative TB/HIV activities. It is intended to facilitate the collection of standardized data and help in the interpretation and dissemination of these data for program improvement. It aims to ensure consistency across all agencies and stakeholders involved in HIV/AIDS, TB, and collaborative TB/HIV activities.